Safer drugs, faster!
Side-effect forecast for smarter decisions through Digital Twin technology.

How to help pharmaceutical research to prioritize drug candidates?

We are a techbio startup using AI-powered predictive modeling to evaluate drug side effects of chemical compounds.

Cytocast SCREENER

Application: From dry lab to wet lab (before new syntheses).
Advantage: Accelerates early detection by selecting the best from thousands of compounds, providing clear ranking reports on potential side effects, helping to focus resources effectively.
Benefits: Candidates that ultimately would have to be excluded are excluded early, saving research teams significant time and significantly more money that the cost of the Cytocast Screener exercise.

Cytocast OPTIMIZER

Application: During early and late-phase preclinical studies.
Advantage: Refines the choice candidates following in vitro and in vivo testing, enriching the understanding of those selected with adverse event analyses and comparative analyses to support confident decisions in the preclinical phase, and eliminating unworthy candidates.
Benefits: Research teams can more confidently focus on the last few candidates in their work of narrowing their selection and defending their project, reducing the time and human energy (money) required to arrive at final selection.

Cytocast NOMINATOR

Application: To select "lead" and "backup" candidates.
Advantage: Provides in-depth reports and detailed outcome analyses of final candidates to optimize clinical trial decision-making.
Benefits: Selection includes state-of-the-art, in-depth consideration of the probabilities of advers effects in clinical trials. The completion of the Cytocast exercise makes a major contribution to the prevention of the disasterous outcome for the project.

Testimonials

Demo

Interested in our products?

How we do it

Cytocast is using computer simulations to determine the most effective treatment for patients while minimazing potential side effects

0

Proteins per tissue

0

Binding sites per tissue

0

Predictable side effects

0

Regulatory pathways

0

Tissue types

Blog

Press Release: Cytocast Launches Three AI-Powered Products to Predict and Mitigate Drug Side-Effect Risk as Early as in Discovery and Preclinical Development

2025-10-30

Cytocast announced the market entry of three leading-edge products today: Cytocast Screener™, Cytocast Optimizer™, and Cytocast Nominator™ - designed to bring earlier, more interpretable safety insights to drug discovery and preclinical decision-making.

Virtual drug testing: can AI and cell simulations replace lab experiments?

2025-04-02

Using AI and whole-cell simulations, our team at Cytocast is building the next generation of drug discovery tools. The CYTOCAST DIGITAL TWIN Platform™ creates realistic, dynamic models of human cells, capable of simulating billions of molecular interactions per second.

Unraveling COVID-19’s neurological impacts: Insights into microglial dysfunction and CNS inflammation

2025-03-25

A recent study sheds light on the complex molecular and cellular mechanisms underpinning neurological pathologies caused by COVID-19, with a focus on microglial dysfunction and central nervous system (CNS) inflammation.